Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources

Annals of the ICRP

Volumn 35, Issue 3, 2005, Pages

[No Author Info available]

Author keywords

103Pd; 125I; Radiation monitors; Radiological protection; Source expulsion

Indexed keywords

IODINE; MEDICAL IMAGING; ONCOLOGY; PALLADIUM; PATIENT TREATMENT; PHOTONS; RADIOLOGY;

103PD; 125I; RADIATION MONITORS; RADIOLOGICAL PROTECTION; SOURCE EXPULSION;

RADIATION SHIELDING;

IODINE 125; PALLADIUM 103;

ABDOMINAL SURGERY; AIRBORNE PARTICLE; BRACHYTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; FATHER; GENETIC RISK; HUMAN; IMPLANTATION; INFERTILITY; PARENTHOOD; PATIENT CARE; PATIENT EDUCATION; PELVIS SURGERY; POSTHUMOUS CARE; PROSTATE CANCER; RADIATION CARCINOGENESIS; RADIATION DETECTION; RADIATION INJURY; RADIATION MONITORING; RADIATION STERILIZATION; REVIEW; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 28644433906     PISSN: 01466453     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-6453(05)00062-X     Document Type: Review

References (54)

1. M.K. Ankem, V.S. De Carvalho, and A.H. Harangozo Implications of radioactive seed migration to the lungs after prostate brachytherapy Urology 59 2002 555 559
2. L. Chauveinc, A. Osseli, and T. Flam Migration des grains d'iode 125 après curiethérapie prostatique: étude d'une série de 170 patients Cancer/Radiothérapie 8 2004 211 216
3. L.T. Dauer, M. Zelefsky, and C. Horan Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy Brachytherapy 3 2004 1 6
4. Eckerman, K.F., Thompson, E.A., Veinot, K.G. Dose Coefficient for Deterministic Health Effects. ORNL/TM-2003/196. Oak Ridge National Laboratory, Oak Ridge, USA (in press).
5. J.S. Eshleman, B.J. Davis, and T.M. Pisansky Radioactive seed migration to the chest after transperineal interstitial prostate brachytherapy: extraprostatic seed placement correlates with migration Int. J. Radiat. Oncol. Biol. Phys. 59 2004 419 425
6. French Decree No. 2002-460, 2002. Journal Officiel de la République Française.
7. P.D. Grimm, J. Blasko, and H. Ragde Migration of iodine-125 and palladium-103 seeds to the lung after transperineal brachytherapy for prostate cancer Endocurie/Hypertherm. Oncol. 9 1993 90
8. IAEA, 1996. BSS Safety Series No. 115. Food and Agriculture Organization of the United Nations, International Atomic Energy Agency, International Labour Organization, OECD Nuclear Energy Agency, Pan American Health Organization, World Health Organization, Vienna.
9. IAEA, 2002b. Advisory Material for the IAEA Regulations for the Safe Transport of Radioactive Materials. Safety Standards Series No. TS-G.1.1. International Atomic Energy Agency, Vienna.
10. IAEA, 2003. Method for Developing Arrangements for Response to a Nuclear or Radiological Emergency. EPR-METHOD. International Atomic Energy Agency, Vienna.
11. ICRP, 1977. Recommendations of the International Commission on Radiological Protection. ICRP Publication 26, Ann. ICRP.
12. ICRP, 1991. 1990 Recommendations of the International Commission on Radiological Protection. ICRP Publication 60, Ann. ICRP 21(1-3).
13. ICRP, 1996. Radiological protection and safety in medicine. ICRP Publication 73, Ann. ICRP 26.
14. ICRU, 1992. Measurement of Dose Equivalents from External Radiation Sources - Part 2. ICRU Report No. 47. International Commission on Radiation Units and Measurement, Bethesda, MD.
15. IRSN, 2003. Report SDOS 2003-009. Institut de Radioprotection et de Sûreté Nucléaire.
16. Japanese Society for Therapeutic Radiology and Oncology, Japanese Urological Association and Japan Radiological Society, 2003. Guidelines for Safety Control of Brachytherapy with Permanently Implanted Sealed Seed Radiation Sources for Prostate Cancer. Japan Radioisotope Association, Tokyo. In Japanese.
17. G.S. Merrick, W.M. Bulter, and A.T. Dorsey Seed fixity in the prostate/periprostatic region following brachytherapy Int. J. Radiat. Oncol. Phys. 46 2000 215 220
18. J. Michalski, S. Mutic, and J. Eichling Radiation exposure to family and household members after prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 56 2003 764 768
19. S. Nag, D.D. Scaperoth, and R. Badalement Transperineal palladium 103 prostate brachytherapy: analysis of morbidity and seed migration Urology 45 1995 87 92
20. S. Nag, V. Singavajhala, and R. Martinez-Monge Pulmonary embolization of permanently implanted radioactive palladium-103 seeds for carcinoma of the prostate Int. J. Radiat. Oncol. Biol. Phys. 39 1997 667 670
21. R. Nath, L.L. Anderson, and J.A. Meli Cremated remains should not be scattered in the environment until a minimum of ten half-lives has elapsed from the date of the implant (AAPM TG-56) Med. Phys. 24 1997 1557 1598
22. NCRP, 1970. Precautions in the Management of Patients who have Received Therapeutic Amounts of Radionuclides. NCRP Report No. 37. National Council on Radiation Protection and Measurements, Bethesda, MD.
23. NCRP, 1995. Use of Personal Monitors to Estimate Effective Dose Equivalent and Effective Dose to Workers for External Exposure to Low-LET Radiation. NCRP Report No. 122. National Council on Radiation Protection and Measurements, Bethesda, MD.
24. NCRP, 1996. Screening Models for Releases of Radionuclides to Atmosphere, Surface Water, and Ground. NCRP Report No. 123. National Council on Radiation Protection and Measurements, Bethesda, MD.
25. R.A. Older, B. Synder, and T.L. Krupski Radioactive implant migration in patients treated for localized prostate cancer with interstitial brachytherapy J. Urol. 165 2001 1590 1592
26. 125I prostate implant patient J. Appl. Med. Phys. 2 2001 174 177
27. S. Smathers, K. Wallner, and T. Korssjoew Radiation safety parameters following prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 45 1999 397 399
28. A.D. Steinfeld, B.R. Donahuue, and L. Plaine Pulmonary embolization of iodine-125 seeds following prostate implantation Urology 37 1991 149 150
29. M. Stutz, J. Petrikas, and M. Raslowsky Seed loss through the urinary tract after prostate brachytherapy: examining the role of cystoscopy and straining post-implant Med. Phys. 30 2003 2695 2698
30. E.M. Tapen, J.C. Blasko, and P.D. Grimm Reduction of radioactive seed embolization to the lung following prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 42 1998 1063 1067
31. US NRC, 1988. A Regulatory Analysis on Emergency Preparedness for Fuel Cycle and Other Radioactive Material Licensees. US Nuclear Power Plants. NUREG-1140. US Nuclear Regulatory Commission, Washington, DC.
32. US NRC, 2002. Consolidated Guidance about Material Licenses, Program-Specific Guidance about Medical Use Licenses. NUREG-1556. US Nuclear Regulatory Commission. U-1-U-27.
33. G.J. Welle, and K. Quinn Pulmonary embolization of iodine-125 implants AJR Am. J. Roentgenol. 159 1992 218
34. Y. Yumoto, T. Hanafusa, and T. Nagamatsu Experimental incineration of low level radioactive samples Health Phys. 79 Suppl. 2 2000 S25 S32
35. J.N. Aronowitz Dawn of prostate brachytherapy: 1915-1930 Int. J. Radiat. Oncol. Biol. Phys. 54 2002 712 718
36. C. Buron, L. Chauveinc, and N. Salem An economic evaluation of interstitial brachytherapy, radical prostatectomy and external beam radiotherapy for localized prostate cancer: results during the first year after therapy Radiother. Oncol. 71 Suppl. 2 2004 S86
37. P.D. Grimm, J.C. Blasko, and J.E. Sylvester 10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 51 2001 31 40
38. B.S. Hilaris, M.E. Batata, and L.L. Anderson Chapter 26 B. Pierquin J.F. Wilson D. Chassagne Prostate in Modern Brachytherapy 1987 Masson New York 234 247
39. M.A. Kollmeier, R.G. Stock, and N. Stone Biochemical outcomes after prostate brachytherapy with 5-year minimal follow-up: importance of patient selection and implant quality Int. J. Radiat. Oncol. Biol. Phys. 57 2003 645 653
40. P.A. Kupelian, L. Potters, and D. Khuntia Radical prostatectomy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 58 2004 25 33
41. Langley, S.E., Laing, R.W., 2004. Iodine seed prostate brachytherapy: an alternative first-line choice for early prostate cancer. Prostate Cancer Prostatic Dis.
42. M.J. Marchese, D. Nori, and L.L. Anderson A versatile permanent planar implant technique utilizing iodine-125 seeds imbedded in gelfoam Int. J. Radiat. Oncol. Biol. Phys. 10 1984 747 751
43. J. Michalski, S. Mutic, J. Eichling, and S.N. Ahmed Radiation exposure to family and household members after prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 56 2003 764 768
44. O. Pasteau, and P. Degrais De l'emploi du radium dans les cancers de la prostate J. Urol. (Paris) 4 1913 341 345
45. L. Potters, E.A. Klein, and M.W. Kattan Monotherapy for stage T1-T2 prostate cancer: radical prostatectomy, external beam radiotherapy, or permanent seed implantation Radiother. Oncol. 71 2004 29 33
46. H. Ragde, L.J. Korb, and A.A. Elgamal Modern prostate brachytherapy. Prostate specific antigen results in 219 patients with up to 12 years of observed follow-up Cancer 89 2000 135 141
47. S. Smathers, K. Wallner, and T. Korssjoew Radiation safety parameters following prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 45 1999 397 399
48. N.N. Stone, and R.G. Stock Permanent seed implantation for localized adenocarcinoma of the prostate Curr. Urol. Rep. 3 2002 201 206
49. 103Pd brachytherapy: Seattle fifteen year outcome results Radiother. Oncol. 71 Suppl. 2 2004 S17
50. J.E. Sylvester, J.C. Blasko, and P.D. Grimm Fifteen year follow up of the first cohort of localized prostate cancer patients treated with brachytherapy J. Clin. Oncol. 22 2004 14S 398S
51. Woolsey, J., Miller, N., Theodorescu, D., 2003. Permanent interstitial brachytherapy for prostate cancer: a current review. World J. Urol.
52. 125I implantation of the prostate for clinically localized prostate cancer J. Urol. 158 1997 23 30
53. 125I prostate implantation for patients with localized prostate cancer Int. J. Radiat. Oncol. Biol. Phys. 47 2000 1261 1266
54. M.J. Zelefsky, Y. Yamada, C. Marion, S. Sim, G. Cohen, L. Ben-Porat, D. Silvern, and M. Zaider Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapy Int. J. Radiat. Oncol. Biol. Phys. 55 2003 956 963